174 related articles for article (PubMed ID: 24875758)
1. Lentiviral MGMT(P140K)-mediated in vivo selection employing a ubiquitous chromatin opening element (A2UCOE) linked to a cellular promoter.
Phaltane R; Lachmann N; Brennig S; Ackermann M; Modlich U; Moritz T
Biomaterials; 2014 Aug; 35(25):7204-13. PubMed ID: 24875758
[TBL] [Abstract][Full Text] [Related]
2. Long-term reproducible expression in human fetal liver hematopoietic stem cells with a UCOE-based lentiviral vector.
Dighe N; Khoury M; Mattar C; Chong M; Choolani M; Chen J; Antoniou MN; Chan JK
PLoS One; 2014; 9(8):e104805. PubMed ID: 25118036
[TBL] [Abstract][Full Text] [Related]
3. Drug selection of mutant methylguanine methyltransferase from different oncoretroviral backbones results in multilineage hematopoietic transgene expression in primary and secondary recipients.
Davis BM; Reese JS; Lingas K; Gerson SL
J Hematother Stem Cell Res; 2003 Aug; 12(4):375-87. PubMed ID: 12965075
[TBL] [Abstract][Full Text] [Related]
4. Efficiency and safety of O⁶-methylguanine DNA methyltransferase (MGMT(P140K))-mediated in vivo selection in a humanized mouse model.
Phaltane R; Haemmerle R; Rothe M; Modlich U; Moritz T
Hum Gene Ther; 2014 Feb; 25(2):144-55. PubMed ID: 24218991
[TBL] [Abstract][Full Text] [Related]
5. Physiological regulation of transgene expression by a lentiviral vector containing the A2UCOE linked to a myeloid promoter.
Brendel C; Müller-Kuller U; Schultze-Strasser S; Stein S; Chen-Wichmann L; Krattenmacher A; Kunkel H; Dillmann A; Antoniou MN; Grez M
Gene Ther; 2012 Oct; 19(10):1018-29. PubMed ID: 22071971
[TBL] [Abstract][Full Text] [Related]
6. In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning.
Zielske SP; Reese JS; Lingas KT; Donze JR; Gerson SL
J Clin Invest; 2003 Nov; 112(10):1561-70. PubMed ID: 14617757
[TBL] [Abstract][Full Text] [Related]
7. Limited lentiviral transgene expression with increasing copy number in an MGMT selection model: lack of copy number selection by drug treatment.
Zielske SP; Lingas KT; Li Y; Gerson SL
Mol Ther; 2004 Jun; 9(6):923-31. PubMed ID: 15194059
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells.
Zhang F; Thornhill SI; Howe SJ; Ulaganathan M; Schambach A; Sinclair J; Kinnon C; Gaspar HB; Antoniou M; Thrasher AJ
Blood; 2007 Sep; 110(5):1448-57. PubMed ID: 17456723
[TBL] [Abstract][Full Text] [Related]
9. Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells.
Ragg S; Xu-Welliver M; Bailey J; D'Souza M; Cooper R; Chandra S; Seshadri R; Pegg AE; Williams DA
Cancer Res; 2000 Sep; 60(18):5187-95. PubMed ID: 11016647
[TBL] [Abstract][Full Text] [Related]
10. The P140K mutant of human O(6)-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O(6)-(4-bromothenyl)guanine.
Woolford LB; Southgate TD; Margison GP; Milsom MD; Fairbairn LJ
J Gene Med; 2006 Jan; 8(1):29-34. PubMed ID: 16075413
[TBL] [Abstract][Full Text] [Related]
11. MGMT enrichment and second gene co-expression in hematopoietic progenitor cells using separate or dual-gene lentiviral vectors.
Roth JC; Alberti MO; Ismail M; Lingas KT; Reese JS; Gerson SL
Virus Res; 2015 Jan; 196():170-80. PubMed ID: 25479595
[TBL] [Abstract][Full Text] [Related]
12. Reversal of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced severe immunodeficiency by transduction of murine long-lived hemopoietic progenitor cells using O6-methylguanine DNA methyltransferase complementary DNA.
Maze R; Kapur R; Kelley MR; Hansen WK; Oh SY; Williams DA
J Immunol; 1997 Jan; 158(2):1006-13. PubMed ID: 8993023
[TBL] [Abstract][Full Text] [Related]
13. In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication.
Davis BM; Humeau L; Dropulic B
Mol Ther; 2004 Feb; 9(2):160-72. PubMed ID: 14759800
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of a P140K mutant O6-methylguanine-DNA-methyltransferase (MGMT)-expressing transgenic mouse line with drug-selectable bone marrow.
Kramer BA; Lemckert FA; Alexander IE; Gunning PW; McCowage GB
J Gene Med; 2006 Sep; 8(9):1071-85. PubMed ID: 16927363
[TBL] [Abstract][Full Text] [Related]
15. A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny.
Pfaff N; Lachmann N; Ackermann M; Kohlscheen S; Brendel C; Maetzig T; Niemann H; Antoniou MN; Grez M; Schambach A; Cantz T; Moritz T
Stem Cells; 2013 Mar; 31(3):488-99. PubMed ID: 23307570
[TBL] [Abstract][Full Text] [Related]
16. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.
Schambach A; Bohne J; Chandra S; Will E; Margison GP; Williams DA; Baum C
Mol Ther; 2006 Feb; 13(2):391-400. PubMed ID: 16226060
[TBL] [Abstract][Full Text] [Related]
17. A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines.
Richard E; Géronimi F; Lalanne M; Ged C; Redonnet-Vernhet I; Lamrissi-Garcia I; Gerson SL; de Verneuil H; Moreau-Gaudry F
J Gene Med; 2003 Sep; 5(9):737-47. PubMed ID: 12950064
[TBL] [Abstract][Full Text] [Related]
18. A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors.
Zhang F; Frost AR; Blundell MP; Bales O; Antoniou MN; Thrasher AJ
Mol Ther; 2010 Sep; 18(9):1640-9. PubMed ID: 20588258
[TBL] [Abstract][Full Text] [Related]
19. Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O(6)-methylguanine-DNA methyltransferase(P140K).
Maier P; Spier I; Laufs S; Veldwijk MR; Fruehauf S; Wenz F; Zeller WJ
Gene Ther; 2010 Mar; 17(3):389-99. PubMed ID: 19865182
[TBL] [Abstract][Full Text] [Related]
20. Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy.
Ackermann M; Lachmann N; Hartung S; Eggenschwiler R; Pfaff N; Happle C; Mucci A; Göhring G; Niemann H; Hansen G; Schambach A; Cantz T; Zweigerdt R; Moritz T
Biomaterials; 2014 Feb; 35(5):1531-42. PubMed ID: 24290698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
